Effect of triple versus dual antiplatelet therapy in patients undergoing percutaneous intervention: systematic review and meta-analysis with GRADE system
TAT appears to be more effective than DAT in reducing MACEs, TLR, and TVR in acute coronary syndrome patients after PCI. TAT is almost as safe as DAT in these patients because there is a statistically insignificant difference in most of the adverse effects between these two groups.
Authors
- Rahma Sameh Shaheen (ORCID: https://orcid.org/0000-0001-5200-6138)
- Ahmed Saad Elsaeidy (ORCID: https://orcid.org/0000-0002-1643-9750)
- Hesham Elsayed (ORCID: https://orcid.org/0000-0001-9364-7409)
- Noran Magdy Shalma (ORCID: https://orcid.org/0000-0001-9231-7213)
- Reem Sayad (ORCID: https://orcid.org/0000-0002-4378-2714)
- Shimaa Essam El-Din Hmd
- Mohamed K. Harfoush
- Islam Mohsen Elhaddad
- Rana Abdelnassar Abdelrahman
- Afag Abdullah Algunaid Babeker
Institutions
- Damietta University (EG)
- Al-Azhar University (EG)
- Benha University (EG)
- Tanta University (EG)
- National Ribat University (SD)
- Military Medical Academy (EG)
- Alexandria University (EG)
- Assiut University (EG)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1097/ms9.0000000000004511
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00